Cohen L, Roth S Coping with abortion. J Human Stress. 1984 Fall;10(3):140-5.
De Genna NM, Feske U, Larkby C, Angiolieri T, Gold MA Pregnancies, abortions, and births among women with and without borderline personality disorder. Womens Health Issues. 2012 Jul-Aug;22(4):e371-7. doi: 10.1016/j.whi.2012.05.002.
Dehlendorf C, Harris LH, Weitz TA Disparities in abortion rates: a public health approach. Am J Public Health. 2013 Oct;103(10):1772-9. doi: 10.2105/AJPH.2013.301339. Epub 2013 Aug 15.
Dehlendorf C, Weitz T Access to abortion services: a neglected health disparity. J Health Care Poor Underserved. 2011 May;22(2):415-21. doi: 10.1353/hpu.2011.0064.
Drower SJ, Nash ES Therapeutic abortion on psychiatric grounds. Part I. A local study. S Afr Med J. 1978 Oct 7;54(15):604-8.
Mota NP, Burnett M, Sareen J Associations between abortion, mental disorders, and suicidal behaviour in a nationally representative sample. Can J Psychiatry. 2010 Apr;55(4):239-47.
Munk-Olsen T, Laursen TM, Pedersen CB, Lidegaard O, Mortensen PB First-time first-trimester induced abortion and risk of readmission to a psychiatric hospital in women with a history of treated mental disorder. Arch Gen Psychiatry. 2012 Feb;69(2):159-65. doi: 10.1001/archgenpsychiatry.2011.153.
Niswander KR, Singer J, Singer M Psychological reaction to therapeutic abortion. II. Objective response. Am J Obstet Gynecol. 1972 Sep 1;114(1):29-33.
Pérez G, Ruiz-Muñoz D, Gotsens M, Cases MC, Rodríguez-Sanz M Social and economic inequalities in induced abortion in Spain as a function of individual and contextual factors. Eur J Public Health. 2014 Feb;24(1):162-9. doi: 10.1093/eurpub/ckt104. Epub 2013 Jul 31.
Roller CG Sexually compulsive/addictive behaviors in women: a women's healthcare issue. J Midwifery Womens Health. 2007 Sep-Oct;52(5):486-91. Review.
Sharma V, Sommerdyk C, Sharma S Post-abortion mania. Arch Womens Ment Health. 2013 Apr;16(2):167-9. doi: 10.1007/s00737-013-0328-0. Epub 2013 Feb 5.
Simoila L, Isometsä E, Gissler M, Suvisaari J, Sailas E, Halmesmäki E, Lindberg N Schizophrenia and induced abortions: A national register-based follow-up study among Finnish women born between 1965-1980 with schizophrenia or schizoaffective disorder. Schizophr Res. 2018 Feb;192:142-147. doi: 10.1016/j.schres.2017.05.039. Epub 2017 Jun 12.
Smith EM A follow-up study of women who request abortion. Am J Orthopsychiatry. 1973 Jul;43(4):574-85.
Steinberg JR, Finer LB Examining the association of abortion history and current mental health: A reanalysis of the National Comorbidity Survey using a common-risk-factors model. Soc Sci Med. 2011 Jan;72(1):72-82. doi: 10.1016/j.socscimed.2010.10.006. Epub 2010 Oct 23.
Taft AJ, Watson LF, Lee C Violence against young Australian women and association with reproductive events: a cross-sectional analysis of a national population sample. Aust N Z J Public Health. 2004 Aug;28(4):324-9.
Taft AJ, Watson LF Termination of pregnancy: associations with partner violence and other factors in a national cohort of young Australian women. Aust N Z J Public Health. 2007 Apr;31(2):135-42.
Uria M, Mosquera C Legal abortion in Asturias (Spain) after the 1985 law: sociodemographic characteristics of women applying for abortion. Eur J Epidemiol. 1999 Jan;15(1):59-64.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
